You hear a lot about new computer programs, like AI chatbots (ChatGPT, Claude, Gemini, etc.) that can give you fast answers. But when it comes to your health, a fast answer can be a very wrong answer. When you’re dealing with asthma and allergies, you want advice you can trust. The Danger of an AI…
When people think of food allergy symptoms, they often picture sudden, dramatic and severe reactions. But not all food allergy symptoms are severe. In fact, many people experience mild food reactions. How do you know if you or a loved one is experiencing a mild food reaction vs. a severe food reaction? A recent survey…
The peanut allergy treatment Palforzia® will be discontinued on July 31, 2026, according to its manufacture.
FAIRFAX, VA, FEB. 13, 2026 – Allergy & Asthma Network issued the following statement in response to the U.S. Environmental Protection Agency’s (EPA) final decision on Feb. 12 to repeal the 2009 Endangerment Finding: Allergy & Asthma Network strongly opposes the EPA’s decision to implement final repeal of the 2009 Endangerment Finding. “This action…
Join us for a FREE webinar | April 16, 2026| 4 PM ET Chronic urticaria is a complex and often persistent condition that presents ongoing management challenges for clinicians. Optimal care frequently requires a stepwise therapeutic approach, careful monitoring of treatment response, and familiarity with emerging therapies as the treatment landscape continues to evolve. In…
If your child has or may have a peanut allergy, we ask you to consider the COMFORT Toddlers study. It may help us learn more about treating peanut allergy in toddlers.
If you or a loved one live with a food allergy, then you know the importance of reading food labels. Food labels identify the ingredients in your food. They also highlight if common allergens are present. What can you do if you have a severe allergic reaction to a food you thought was “safe” based…
Consider enrolling in the BLU-808-1201 clinical research study. You may qualify if you have chronic spontaneous urticaria and are still experiencing symptoms such as hives even after taking antihistamines. Participation lasts at least 4 months and includes the following:
Allergy & Asthma Network applauds Congress for approving funding for the CDC’s National Asthma Control Program.
You are invited to attend the 29th annual Allergy & Asthma Day Capitol Hill (AADCH) advocacy day on Wednesday, May 6 in Washington, DC. Join fellow advocates to meet with members of Congress and their staff, and lend your voice on behalf of millions of people living with asthma, allergies and related conditions in the…
By Nissa Shaffi, Director of Advocacy, Allergy & Asthma Network In January 2026, the U.S. Department of Health and Human Services (HHS) and the U.S. Centers for Disease Control and Prevention (CDC) announced major changes to the childhood immunization schedule, reducing the number of recommended vaccines from 17 to 11. Current vaccine recommendations CDC now…
Join Us for a FREE Webinar | March 18, 2026 | 1 PM ET Despite advances in treatment, many patients with asthma remain uncontrolled, experiencing frequent exacerbations, persistent symptoms, and reduced quality of life. Managing severe and uncontrolled asthma requires a personalized, evidence-based approach that accounts for disease heterogeneity, comorbidities, and patient-specific factors. Join us…
End of content
End of content
10304 Eaton Place, Suite 100
Fairfax, VA 22030
Phone: 800-878-4403
Join Our Newsletter
Keep up with the latest news from AAN, right in your inbox! Choose from our eNewsletter, Research or EXHALE newsletters.
🔐 We do not share or sell your information.
Featured Topics & Toolkits
2026 Allergy & Asthma Network | All Rights Reserved
